ONCIRE Trademark

Trademark Overview

On Thursday, July 15, 2010, a trademark application was filed for ONCIRE with the United States Patent and Trademark Office. The USPTO has given the ONCIRE trademark a serial number of 85085123. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 10, 2014. This trademark is owned by Novartis AG. The ONCIRE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antibiotics; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders, for use in dermatology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
oncire

General Information

Serial Number85085123
Word MarkONCIRE
Filing DateThursday, July 15, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 10, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2010

Trademark Statements

Goods and ServicesAnti-infectives; Antibiotics; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders, for use in dermatology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 20, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, March 10, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 10, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 12, 2013EXTENSION 5 GRANTED
Wednesday, July 31, 2013EXTENSION 5 FILED
Wednesday, July 31, 2013TEAS EXTENSION RECEIVED
Thursday, February 7, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 6, 2013EXTENSION 4 GRANTED
Thursday, January 31, 2013EXTENSION 4 FILED
Thursday, January 31, 2013TEAS EXTENSION RECEIVED
Thursday, August 9, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 8, 2012EXTENSION 3 GRANTED
Tuesday, July 31, 2012EXTENSION 3 FILED
Tuesday, July 31, 2012TEAS EXTENSION RECEIVED
Thursday, March 1, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 29, 2012EXTENSION 2 GRANTED
Tuesday, January 31, 2012EXTENSION 2 FILED
Monday, February 27, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 31, 2012TEAS EXTENSION RECEIVED
Tuesday, August 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 29, 2011EXTENSION 1 GRANTED
Friday, July 29, 2011EXTENSION 1 FILED
Friday, July 29, 2011TEAS EXTENSION RECEIVED
Tuesday, February 1, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 7, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 7, 2010PUBLISHED FOR OPPOSITION
Thursday, November 4, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 4, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 3, 2010EXAMINER'S AMENDMENT ENTERED
Tuesday, November 2, 2010EXAMINER'S AMENDMENT ENTERED
Tuesday, November 2, 2010ASSIGNED TO LIE
Tuesday, November 2, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 2, 2010EXAMINERS AMENDMENT E-MAILED
Tuesday, November 2, 2010EXAMINERS AMENDMENT -WRITTEN
Friday, October 8, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 8, 2010NON-FINAL ACTION E-MAILED
Friday, October 8, 2010NON-FINAL ACTION WRITTEN
Friday, October 8, 2010ASSIGNED TO EXAMINER
Tuesday, July 20, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 19, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

oncire system disorders preparations diseases pharmaceutical treatment prevention skeletal genitourinary musculo